SG151288A1 - 3-cyano-quinoline derivatives with antiproliferative activity - Google Patents
3-cyano-quinoline derivatives with antiproliferative activityInfo
- Publication number
- SG151288A1 SG151288A1 SG200901893-8A SG2009018938A SG151288A1 SG 151288 A1 SG151288 A1 SG 151288A1 SG 2009018938 A SG2009018938 A SG 2009018938A SG 151288 A1 SG151288 A1 SG 151288A1
- Authority
- SG
- Singapore
- Prior art keywords
- cyano
- antiproliferative activity
- quinoline derivatives
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP03/51059 | 2003-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG151288A1 true SG151288A1 (en) | 2009-04-30 |
Family
ID=34684508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200901893-8A SG151288A1 (en) | 2003-12-18 | 2004-12-15 | 3-cyano-quinoline derivatives with antiproliferative activity |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US7655642B2 (ko) |
| EP (1) | EP1696914B1 (ko) |
| JP (1) | JP4892353B2 (ko) |
| KR (1) | KR101158440B1 (ko) |
| CN (1) | CN1893944B (ko) |
| AR (1) | AR047060A1 (ko) |
| AT (1) | ATE446750T1 (ko) |
| AU (1) | AU2004298784B2 (ko) |
| BR (1) | BRPI0417609B8 (ko) |
| CA (1) | CA2549728C (ko) |
| DE (1) | DE602004023876D1 (ko) |
| EA (1) | EA200601176A1 (ko) |
| ES (1) | ES2335216T3 (ko) |
| HK (1) | HK1095742A1 (ko) |
| IL (1) | IL176358A (ko) |
| MX (1) | MXPA06007018A (ko) |
| NO (1) | NO337622B1 (ko) |
| NZ (1) | NZ547795A (ko) |
| SG (1) | SG151288A1 (ko) |
| TW (2) | TWI374879B (ko) |
| UA (1) | UA83880C2 (ko) |
| WO (1) | WO2005058318A1 (ko) |
| ZA (1) | ZA200604971B (ko) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2549869C (en) | 2003-12-18 | 2015-05-05 | Janssen Pharmaceutica N.V. | Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
| DE602004023876D1 (de) | 2003-12-18 | 2009-12-10 | Janssen Pharmaceutica Nv | 3-cyano-chinolin-derivate mit antiproliferativer wirkung |
| MY169441A (en) | 2004-12-08 | 2019-04-11 | Janssen Pharmaceutica Nv | 2,4, (4,6) pyrimidine derivatives |
| NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
| JO3088B1 (ar) * | 2004-12-08 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف |
| US10517876B2 (en) | 2005-11-16 | 2019-12-31 | Cti Biopharma Corp. | Oxygen linked pyrimidine derivatives |
| WO2007058628A1 (en) | 2005-11-16 | 2007-05-24 | S*Bio Pte Ltd | Heteroalkyl linked pyrimidine derivatives |
| BRPI0714211B8 (pt) * | 2006-07-13 | 2021-05-25 | Janssen Pharmaceutica Nv | derivados de mtki quinazolina, sua utilização e composição farmacêutica que os compreende |
| JPWO2008087736A1 (ja) * | 2007-01-19 | 2010-05-06 | 宇部興産株式会社 | アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法 |
| JP5385268B2 (ja) * | 2007-06-21 | 2014-01-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | インドリン−２−オンおよびアザ−インドリン−２−オン |
| CA2693715C (en) | 2007-07-27 | 2015-10-27 | Janssen Pharmaceutica Nv | Pyrrolopyrimidines |
| CN102127087B (zh) * | 2011-01-21 | 2012-07-04 | 江苏先声药物研究有限公司 | 喹唑啉衍生物 |
| MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
| MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
| MX2018004109A (es) | 2015-10-05 | 2018-09-27 | Univ Columbia | Activadores de flujo autofágico y fosfolipasa d y depuración de acumulaciones de proteína que incluyen tau y tratamiento de proteinopatías. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028613A (en) | 1990-02-16 | 1991-07-02 | Repligen Corporation | Novel pyrroloquinoline alkaloids and methods of use |
| UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
| US6288082B1 (en) * | 1998-09-29 | 2001-09-11 | American Cyanamid Company | Substituted 3-cyanoquinolines |
| JP4548642B2 (ja) * | 1998-09-29 | 2010-09-22 | アメリカン・サイアナミド・カンパニー | プロテインチロシンキナーゼインヒビターとしての置換３−シアノキノリン |
| PL371188A1 (en) | 2002-03-30 | 2005-06-13 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| JO2785B1 (en) | 2003-05-27 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinazoline derivatives |
| DE602004023876D1 (de) | 2003-12-18 | 2009-12-10 | Janssen Pharmaceutica Nv | 3-cyano-chinolin-derivate mit antiproliferativer wirkung |
-
2004
- 2004-12-15 DE DE602004023876T patent/DE602004023876D1/de active Active
- 2004-12-15 CN CN2004800375666A patent/CN1893944B/zh active Active
- 2004-12-15 KR KR1020067014235A patent/KR101158440B1/ko active IP Right Grant
- 2004-12-15 WO PCT/EP2004/053497 patent/WO2005058318A1/en active Application Filing
- 2004-12-15 JP JP2006544439A patent/JP4892353B2/ja active Active
- 2004-12-15 AU AU2004298784A patent/AU2004298784B2/en active Active
- 2004-12-15 SG SG200901893-8A patent/SG151288A1/en unknown
- 2004-12-15 ES ES04804849T patent/ES2335216T3/es active Active
- 2004-12-15 BR BRPI0417609A patent/BRPI0417609B8/pt active IP Right Grant
- 2004-12-15 UA UAA200607006A patent/UA83880C2/ru unknown
- 2004-12-15 NZ NZ547795A patent/NZ547795A/xx unknown
- 2004-12-15 MX MXPA06007018A patent/MXPA06007018A/es active IP Right Grant
- 2004-12-15 EA EA200601176A patent/EA200601176A1/ru unknown
- 2004-12-15 EP EP04804849A patent/EP1696914B1/en active Active
- 2004-12-15 AT AT04804849T patent/ATE446750T1/de not_active IP Right Cessation
- 2004-12-15 CA CA2549728A patent/CA2549728C/en active Active
- 2004-12-15 US US10/596,509 patent/US7655642B2/en active Active
- 2004-12-17 AR ARP040104751A patent/AR047060A1/es active IP Right Grant
- 2004-12-17 TW TW093139380A patent/TWI374879B/zh active
- 2004-12-17 TW TW100107837A patent/TWI389890B/zh active
-
2006
- 2006-06-15 IL IL176358A patent/IL176358A/en active IP Right Grant
- 2006-06-15 ZA ZA200604971A patent/ZA200604971B/xx unknown
- 2006-07-18 NO NO20063324A patent/NO337622B1/no unknown
-
2007
- 2007-03-19 HK HK07102919.7A patent/HK1095742A1/xx unknown
-
2009
- 2009-11-24 US US12/624,708 patent/US8778920B2/en active Active
-
2013
- 2013-03-12 US US13/796,377 patent/US9040511B2/en active Active
-
2014
- 2014-05-23 US US14/285,760 patent/US9365517B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063324L (no) | 3-cyano-kinolinderivater med antiproliferativ aktivitet | |
| GB0124933D0 (en) | Chemical compounds | |
| UA84010C2 (en) | Macrocyclic quinazoline derivatives as antiproliferative agents | |
| DE60112974D1 (en) | Carbolinderivate | |
| AP1718A (en) | 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors | |
| IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
| MY141196A (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
| PL1771178T3 (pl) | Zastosowanie K-252A i inhibitorów kinazy do zapobiegania lub leczenia patologii związanych z HMGB1 | |
| UA93351C2 (uk) | Похідні фталазіну як інгібітори parp | |
| WO2004037176A3 (en) | Quinazolinones and derivatives thereof as factor xa inhibitors | |
| TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
| GEP20094785B (en) | Pyrrolopyrazoles, potent kinase inhibitors | |
| WO2006061417A3 (en) | Macrocyclic quinazole derivatives and their use as mtki | |
| BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
| MY132106A (en) | New pyridazin-3(2h)-one derivatives | |
| WO2003048081A3 (en) | Glycinamides as factor xa inhibitors | |
| NO20070529L (no) | Kinazolindionderivater som parp-inhibitorer | |
| DE60216233D1 (en) | Carbolinderivate | |
| EP1675552A4 (en) | PREPARATION OF 1,6-DISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS | |
| HK1118534A1 (en) | Thieno-pyrimidine compounds having fungicidal activity | |
| WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
| WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
| TW200628153A (en) | Novel compounds | |
| GEP20105095B (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
| RS20060072A (en) | Aminoquinoline derivatives and their use as adenosine a3 ligands |